Therefore, this study aimed to measure the activity of purinergic enzymes, such as NTPDase (CD39) and ecto-5′-nucleotidase (CD73) as well as adenosine deaminase (ADA) in platelets of patients with CKD that performed a resistance physical protocol of 12 weeks undergoing hemodialysis. This evidence concerns the gene ADA and chronic kidney disease.